« When we identified Professor Drouet's technology at the UJF it was immediately apparent that this invention met all our needs. The technology transfer process thereafter was carried out both efficiently and quickly. Floralis, the subsidiary of the UJF quickly drafted a licence agreement which we signed in August 2007.   Our product, Immunoquick EBV M (a diagnostic testing kit for Epstein Barr Virus) was developed soon thereafter. The product is the first fast-acting diagnosis kit for EBV in the world and we believe that this product launch will result in us achieving a significant share of the market within the next three years"

Thierry Paper

PDG

Biosynex